Cite
HARVARD Citation
Videnovic, A. et al. (2021). Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial. Movement disorders. 36 (10), pp. 2408-2412. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Videnovic, A. et al. (2021). Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial. Movement disorders. 36 (10), pp. 2408-2412. [Online].